Benefitfocus, Inc. (NASDAQ:BNFT) shares moved down -2.85% in last trading session and ended the day at $32.40. BNFT Gross Margin is 44.40% and its has a return on assets of -34.60%. Benefitfocus, Inc. (NASDAQ:BNFT) quarterly performance is -13.58%.
On March 24, 2016, Benefitfocus, Inc. (NASDAQ:BNFT) and certain subsidiaries of the Company entered into the Third Amendment Agreement (the “Amendment”) to the Credit Agreement, dated as of February 20, 2015, as amended on June 16 and December 18, 2015 (the “Credit Agreement”), with Silicon Valley Bank, a lender and the administrative agent and collateral agent, and several other lenders party thereto.
Kindred Healthcare Inc. (NYSE:KND) ended the last trading day at $12.57. Company weekly volatility is calculated as 5.26% and price to cash ratio as 5.13. Kindred Healthcare Inc. (NYSE:KND) showed a weekly performance of 7.71%.
Kindred Healthcare, Inc. (NYSE:KND) released its 2015 Quality, Innovation and Social Responsibility Report that highlights major achievements for the year and shares some of the Company’s solutions for population health in the years ahead.
On 01 April, Papa John’s International Inc. (NASDAQ:PZZA) shares moved up 2.47% and was closed at $55.53. PZZA EPS growth in last 5 year was 13.80%. Papa John’s International Inc. (NASDAQ:PZZA) year to date (YTD) performance is -0.22%.
Papa John International Inc. (NASDAQ:PZZA) ‘s is cheering on the Texas Rangers with a $7 pizza deal every single game day of the 2016 baseball season when you use the LE7SGORANGERS promo code. To spread the word, Papa John’s has teamed up with the Rangers’ legendary player #7, Ivan “Pudge” Rodriguez, to star in its latest commercial.
Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) shares moved up 8.84% in last trading session and ended the day at $9.60. AQXP has a return on assets of -29.60%. Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) quarterly performance is -20.27%.
On 14 March, Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) reported Net loss for 2015 was $21.9 million compared to a net loss of $24.0 million for 2014. The decrease in net loss was primarily due to the reduction in research and development expenditures over the second half of 2015.
Corium International, Inc. (NASDAQ:CORI) caters to the Healthcare space. It has a net profit margin of -80.10% and weekly performance is 10.57%. On the last day of trading company shares ended up at $4.08.
Corium International, Inc. (NASDAQ:CORI), announced that Peter Staple, Corium’s President and Chief Executive Officer, will present at the 15th Annual Needham Healthcare Conference in New York City on Tuesday, April 12, 2016 at 3:40 p.m. Eastern time.
Leave a Reply